🕵️ Reviva Pharmaceuticals Holdings, Inc. ($RVPH)
SEC insider & ownership activity, last 12 months · CIK 1742927 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 3 red-flag 8-Ks in the window, most recently Delisting notice (3.01), May 12, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 9.9% | 13G | Aug 14, 2025 | filing ↗ | |
| CVI Investments, Inc. | 7.2% | 13G | Dec 23, 2024 | filing ↗ | |
| Heights Capital Management, Inc. | 7.2% | 13G | Dec 23, 2024 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 6.2% | 13G | Mar 30, 2026 | filing ↗ | |
| Millennium Management LLC | 6.2% | 13G | Mar 30, 2026 | filing ↗ | |
| Millennium Group Management LLC | 6.2% | 13G | Mar 30, 2026 | filing ↗ | |
| Israel A. Englander | 6.2% | 13G | Mar 30, 2026 | filing ↗ | |
| Barclays PLC | 6.0% | 13G | May 14, 2026 | filing ↗ | |
| UBS Group AG | 5.8% | 13G | May 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Delisting notice (3.01) | May 12, 2026 | filing ↗ |
| Other events (8.01) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 15, 2026 | filing ↗ |
| Other events (8.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 4, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 4, 2026 | filing ↗ |
| Other events (8.01) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 20, 2026 | filing ↗ |
| Other events (8.01) | Jan 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 18, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 18, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 14, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 26, 2025 | filing ↗ |